| Entry |
|
|---|
| Name |
Levobupivacaine (INN);
Novabupi (TN) |
|---|
| Formula |
C18H28N2O
|
|---|
| Exact mass |
288.2202
|
|---|
| Mol weight |
288.4277
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG02030 Anesthetics
DG01675 Local anesthetic
DG01673 Amide type local anesthetic
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
|---|
| Remark |
| Product (DG00807): | D01287<JP> |
|
|---|
| Efficacy |
Anesthetic (local) |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576], CYP1A2 [HSA: 1544]
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N01 ANESTHETICS
N01B ANESTHETICS, LOCAL
N01BB Amides
N01BB10 Levobupivacaine
D08116 Levobupivacaine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG02030 Anesthetics
DG01675 Local anesthetic
DG01673 Amide type local anesthetic
DG00807 Levobupivacaine
D08116 Levobupivacaine
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00807 Levobupivacaine
D08116 Levobupivacaine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00807 Levobupivacaine
D08116 Levobupivacaine
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Sodium channels
SCN1A
D08116 Levobupivacaine (INN)
SCN2A
D08116 Levobupivacaine (INN)
SCN3A
D08116 Levobupivacaine (INN)
SCN4A
D08116 Levobupivacaine (INN)
SCN5A
D08116 Levobupivacaine (INN)
SCN8A
D08116 Levobupivacaine (INN)
SCN9A
D08116 Levobupivacaine (INN)
SCN10A
D08116 Levobupivacaine (INN)
SCN11A
D08116 Levobupivacaine (INN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08116
Drug groups [BR:br08330]
Neuropsychiatric agent
DG02030 Anesthetics
DG01675 Local anesthetic
DG01673 Amide type local anesthetic
DG00807 Levobupivacaine
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00807 Levobupivacaine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00807 Levobupivacaine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 21
1 C1y C 25.9700 -17.7800
2 N1y N 25.9700 -19.1800
3 C5a C 24.7800 -17.0800
4 C1x C 27.2300 -17.0800
5 C1x C 27.2300 -19.8800
6 C1b C 24.7800 -19.8800
7 N1b N 23.5900 -17.7800
8 O5a O 24.7800 -15.6800
9 C1x C 28.4200 -17.7800
10 C1x C 28.4200 -19.1800
11 C1b C 23.5900 -19.1800
12 C8y C 22.4000 -17.0800
13 C1b C 22.4000 -19.8800
14 C8y C 21.1400 -17.7100
15 C8y C 22.4000 -15.6800
16 C1a C 22.4000 -21.2800
17 C8x C 19.9500 -17.0100
18 C1a C 21.1400 -19.1100
19 C8x C 21.2100 -14.9100
20 C1a C 23.3800 -14.6300
21 C8x C 19.9500 -15.6100
BOND 22
1 1 2 1
2 1 3 1 #Down
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 2
8 4 9 1
9 5 10 1
10 6 11 1
11 7 12 1
12 11 13 1
13 12 14 1
14 12 15 2
15 13 16 1
16 14 17 2
17 14 18 1
18 15 19 1
19 15 20 1
20 17 21 1
21 9 10 1
22 19 21 2
|
|---|
